Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study
Domaines
CancerOrigine | Fichiers produits par l'(les) auteur(s) |
---|